T. Rowe Price Associates’s Frontline FRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-23,896
Closed -$396K 2906
2023
Q1
$396K Buy
23,896
+2,165
+10% +$34.1K ﹤0.01% 2208
2022
Q4
$264K Buy
21,731
+1,626
+8% +$20.9K ﹤0.01% 2423
2022
Q3
$220K Buy
20,105
+8,087
+67% +$88.6K ﹤0.01% 2510
2022
Q2
$106K Buy
12,018
+1,178
+11% +$10.7K ﹤0.01% 2747
2022
Q1
$95K Buy
+10,840
New +$85.9K ﹤0.01% 2854
2021
Q4
Sell
-10,131
Closed -$95K 3005
2021
Q3
$95K Buy
+10,131
New +$80.4K ﹤0.01% 2858

Other funds holding FRO

T. Rowe Price Associates's FRO Position: Q2 2023 in Review

T. Rowe Price Associates sold out of Frontline (FRO) in Q2 2023, closing a stake of 23,896 shares — an estimated $396K sold.

T. Rowe Price Associates first reported a position in FRO in Q3 2021 and held it in 6 quarters. The position peaked at $396K in Q1 2023. 163 funds tracked by Wall St. Rank hold FRO as of Q2 2023.

  • T. Rowe Price Associates reported no remaining Frontline position as of Q2 2023 after selling out during the quarter.
  • T. Rowe Price Associates sold 23,896 Frontline shares in Q2 2023, an estimated $396K.
  • T. Rowe Price Associates first reported a position in Frontline in Q3 2021 and held it in 6 quarters.
  • T. Rowe Price Associates's Frontline position peaked at $396K in Q1 2023.
  • 163 funds tracked by Wall St. Rank held Frontline as of Q2 2023.

Based on T. Rowe Price Associates's 13F filing for Q2 2023, filed 14 Aug 2023.